Tharimmune raised $540 M in a Post-IPO round on 2025-11-03.
According to media reports, Tharimmune raised $540 M in a Post-IPO round on 2025-11-03.the investors in this funding round include Liberty City Ventures,DRW Venture Capital,Kraken,Polychain,ARK Invest and others. Following this round, Tharimmune's total funding reached $540 M.
Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
This content is AI-generated.Please verify before use.
Disclaimer: The Crypto Calendar is for informational purposes only and doesn’t reflect Gate.com’s views or serve as financial advice.
Comment
Fundraising History
| Round | Amount | Valuation | Time | Investor(s) |
|---|
